China Resources Medical Holdings Company Limited (CR Medical) released its Monthly Return for Equity Issuer for the period ended 30 June 2026, confirming a stable capital structure during the month.
Authorised Share Capital • Authorised share count remained unchanged at 3.04 billion ordinary shares, each with a par value of HKD 0.00025. • Corresponding authorised share capital stayed at HKD 0.76 million.
Issued Share Capital and Treasury Shares • Issued shares (excluding treasury shares) were unchanged at 1,296.68 million. • The company reported zero treasury shares, leaving total issued shares likewise at 1,296.68 million.
Share Movements • No share issuances, cancellations, repurchases, option exercises, warrant conversions, or other equity-linked issuances occurred during the month. • All sections covering share options, warrants, convertibles and other equity arrangements were marked “Not applicable,” indicating no activity.
Public Float Compliance • CR Medical confirmed compliance with the Hong Kong Main Board’s minimum public float requirement of 25% of issued shares.
Regulatory Filing Details • The filing, signed by Company Secretary Chung Ming Fai and submitted on 2 July 2026, satisfies Hong Kong Stock Exchange Listing Rule 13.25A for monthly returns.
Overall, CR Medical’s June 2026 disclosure highlights an unchanged equity position and continued adherence to public float regulations.
Comments